This investigation of the treatment of Vincent's stomatitis with metronidazole (1-(2-hydroxyethyl)-2-methyl-5-nitroimidazole ; " flagyl ") was stimulated by the observation by Shinn (1962) of the beneficial effect of this compound on seven patients with Vincent's gingivitis.
This investigation of the treatment of Vincent's stomatitis with metronidazole (1-(2-hydroxyethyl)-2-methyl-5-nitroimidazole ; " flagyl ") was stimulated by the observation by Shinn (1962) of the beneficial effect of this compound on seven patients with Vincent's gingivitis.
Methods
The 15 patients investigated were all Africans attending the Jane Furse Memorial Hospital in Transvaal. The diagnosis of Vincent's stomatitis was made initially on clinical evidence and on the typical bacteriological findings on examination of smears from the lesions-namely, the presence of large numbers of spirochaetes with the morphology of Borrelia vincentii and fusiform organisms. Of the 15 patients, 14 had ulcerative gingivitis, while the other had a Vincent's lesion on the right tonsil.
Smears were taken before the beginning of treatment and thereafter twice daily at varying intervals. The initial morning smear was taken before food; the afternoon smear was taken after food, usually porridge. The bacteriological picture was recorded as shown in the key to Table I , and the clinical progress was noted at regular intervals.
Treatment was solely by the oral administration of 200 mg. of metronidazole three times a day for seven days, except in three young children (Cases 11, 14, and 15) , in whom the dose was 100 mg. three times a day for seven days.
The concentration of metronidazole in saliva was investigated in five European volunteers. One volunteer took a single dose of 1 g. of metronidazole on two separate occasions and the other four volunteers took single doses of 200 mg. At the time each sample was taken the mouth was rinsed with water and thereafter the saliva was collected in clean vessels. The samples were assayed polarographically (Kane, 1961) . Table I gives the data on the 15 patients in the trial. The bacteriological findings before and after treatment are also listed, along with the final clinical assessment.
Results
In 14 out of the 15 patients clinical resolution of the lesions was rapid and healing complete, usually by three days. It was difficult in these patients to assess the rapidity with which pain disappeared, relief of pain within a few hours being a feature noted by Shinn (1962 Metronidazole is a well-tolerated compound which has now been administered to tens of thousands of patients for the treatment of trichomoniasis without side-effects, and it would appear to provide a simple and safe therapy for Vincent's infections.
Summary
Fifteen patients with Vincent's stomatitis were treated with metronidazole. In 14 of the 15, clinical resolution of the lesions was rapid, and healing was usually complete within three days. The spirochaetes disappeared within 24 hours, but the disappearance of the fusiform organisms was slower.
Metronidazole is active in vitro against the spirochaetes and against one strain of Bacteroides.
It is not clear if the compound acts by virtue of its presence in the serum or in the saliva, or in both.
It is suggested that it provides an effective form of therapy without the disadvantages of penicillin.
Primary hyperparathyroidism is difficult to recognize when the increased plasma-calcium concentration varies so that it may be within the normal range at times though a tumour is present. Similarly, hypercalciuria is not always found because of renal failure. Moreover, some patients with normal renal function and a raised concentration of calcium in the plasma do not have hypercalciuria. The result is that there is often a need for additional biochemical support before the diagnosis can be established.
In the earlier studies of primary hyperparathyroidism, hyperphosphaturia and hypophosphataemia were found to be characteristic in the absence of renal failure. Albright and Ellsworth (1929) thought the reduced renal resorption of phosphate was the prime effect of parathyroid hormone, changes in calcium metabolism following it. This view was challenged when Collip, Pugsley, Selye, and Thomson (1934) injected parathormone into nephrectomized rats and found a rise in serum-calcium concentration. From this time evidence has accumulated that the main function of the hormone is to raise the ionized-calcium concentration in the plasma by acting directly on bone, and by reversing the protein binding of the ionic calcium (Lloyd, Rose, and Smeenk, 1962) . When parathormone is present in excess, whether experimentally or clinically, changes in renal-phosphate excretion must be interpreted against this background of its primary action on the concentration of ionized-calcium in the plasma. Because this is difficult to measure accurately and also because there are many other causes of hypercalcaemia, we have studied the effects of hyperparathyroidism on phosphate excretion with the aim of providing a supplementary method of diagnosis.
In primary hyperparathyroidism Sirota (1953) found in two patients that the maximal resorptive rate for phosphate was depressed, returning to normal after the adenomas were removed. He attributed the alteration mainly to changes in glomerular filtration rate. Anderson (1955a) 
